Target intelligence / Profile preview

mRNA guanylyltransferase

Molecular classification
Enzyme, Transferase, Nucleotidyltransferase
01

Overview

mRNA guanylyltransferase is a highly conserved enzyme that catalyzes the addition of a guanosine cap (m⁷GpppN) to the 5' end of nascent mRNA during transcription. This three-step mRNA capping process is crucial for mRNA stability, processing, nuclear export, and efficient translation. The enzyme mediates the second step in capping, transferring GMP from GTP to the diphosphate 5' end of pre-mRNA, forming the characteristic cap necessary for proper gene expression in eukaryotes. In mammals, a single bifunctional polypeptide often carries both the RNA triphosphatase and guanylyltransferase activities, while in yeast and many viruses, the enzymes are monofunctional or organized differently[1][2][3][4][5][7]. Structural studies in humans reveal conserved domains critical for substrate recognition and catalysis, with significant evolutionary divergence between mammalian and non-mammalian homologs[1][3][4][7].

Other names
mRNA capping enzymemessenger RNA guanylyltransferaseGTP:mRNA guanylyltransferaseProtein 2
02

Mechanism of action

Inhibitors (theoretical or investigational) would impede mRNA capping, leading to impaired mRNA stability and translation[1][3][5]

03

Biological functions

mRNA cappingGene expression regulationPre-mRNA processingRNA metabolism
04

Disease associations

Other (potentially involved in diseases affecting mRNA processing, but not specifically assigned to common disease categories like cancer without further context)
05

Safety considerations

Inhibition could severely impair gene expression in all eukaryotic cells, leading to toxicity due to widespread disruption of mRNA maturation[5]
06

Interacting drugs

None specifically catalogued as approved or commonly used; research compounds targeting viral homologs may exist, but no widely recognized small-molecule drugs target the human enzyme directly[5]
07

Biomarkers

None established for clinical use; enzyme activity could be an experimental biomarker of mRNA processing integrity

Beyond the preview

Go deeper on mRNA guanylyltransferase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mRNA guanylyltransferase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call